These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33775467)

  • 1. Perioperative Medical Optimization of Symptomatic Benign Prostatic Hyperplasia Is an Economically Justified Infection Prevention Strategy in Total Joint Arthroplasty.
    Moverman MA; Bruha MJ; Pagani NR; Puzzitiello RN; Menendez ME; Barnes CL
    J Arthroplasty; 2021 Jul; 36(7):2551-2557. PubMed ID: 33775467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cost-Effectiveness of Extended Oral Antibiotic Prophylaxis for Infection Prevention After Total Joint Arthroplasty in High-Risk Patients.
    Lipson S; Pagani NR; Moverman MA; Puzzitiello RN; Menendez ME; Smith EL
    J Arthroplasty; 2022 Oct; 37(10):1961-1966. PubMed ID: 35472436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Allergy Testing for Patients Reporting Penicillin and Cephalosporin Allergies is Cost-Effective in Preventing Infection after Total Knee and Hip Arthroplasty.
    Pagani NR; Moverman MA; Puzzitiello RN; Menendez ME; Barnes CL; Kavolus JJ
    J Arthroplasty; 2021 Feb; 36(2):700-704. PubMed ID: 32933797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A break-even analysis of tranexamic acid for prevention of periprosthetic joint infection following total hip and knee arthroplasty.
    Kolin DA; Moverman MA; Menendez ME; Pagani NR; Puzzitiello RN; Kavolus JJ
    J Orthop; 2021; 26():54-57. PubMed ID: 34305348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis.
    Davis NF; Jack GS; Witjes WP; Bjartell A; Caris C; Patel A; de la Taille A; Lawrentschuk N; Bolton DM; Tubaro A
    World J Urol; 2019 May; 37(5):873-878. PubMed ID: 30145778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cost-Effectiveness of Silver-Impregnated Occlusive Dressings for Infection Prevention After Total Joint Arthroplasty.
    Toppo AJ; Pagani NR; Moverman MA; Puzzitiello RN; Menendez ME; Kavolus JJ
    J Arthroplasty; 2021 May; 36(5):1753-1757. PubMed ID: 33281021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A break-even analysis of benzoyl peroxide and hydrogen peroxide for infection prevention in shoulder arthroplasty.
    Menendez ME; Moverman MA; Puzzitiello RN; Pagani NR; Namdari S
    J Shoulder Elbow Surg; 2020 Nov; 29(11):2185-2189. PubMed ID: 32650074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period.
    Naslund MJ; Carlson AM; Williams MJ
    J Urol; 2005 Jun; 173(6):2090-3; discussion 2093. PubMed ID: 15879849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cost-Effectiveness of Normal-Saline Pulsed Lavage for Infection Prophylaxis in Total Joint Arthroplasty.
    Luck T; Zaki P; Michels R; Slotkin EM
    Arthroplast Today; 2022 Dec; 18():107-111. PubMed ID: 36304695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data.
    Morton A; Williams M; Perera M; Teloken PE; Donato P; Ranasinghe S; Chung E; Bolton D; Yaxley J; Roberts MJ
    BJU Int; 2020 Sep; 126 Suppl 1():18-26. PubMed ID: 32558340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost and effectiveness analysis of treatments for benign prostatic hyperplasia].
    Zhong C; Wen W; Xia S
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(4):289-92. PubMed ID: 26879791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term cost effectiveness of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Pharmacoeconomics; 2006; 24(2):171-91. PubMed ID: 16460137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Evaluation Study (Cheer Compliant) Laser Prostatectomy for Benign Prostatic Hyperplasia: Outcomes and Cost-effectiveness.
    Hsu YC; Lin YH; Chou CY; Hou CP; Chen CL; Chang PL; Tsui KH
    Medicine (Baltimore); 2016 Feb; 95(5):e2644. PubMed ID: 26844483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life.
    Djavan B
    Urology; 2003 Sep; 62(3 Suppl 1):6-14. PubMed ID: 12957195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended Oral Antibiotic Prophylaxis in High-Risk Patients Substantially Reduces Primary Total Hip and Knee Arthroplasty 90-Day Infection Rate.
    Inabathula A; Dilley JE; Ziemba-Davis M; Warth LC; Azzam KA; Ireland PH; Meneghini RM
    J Bone Joint Surg Am; 2018 Dec; 100(24):2103-2109. PubMed ID: 30562290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic Benign Prostatic Hyperplasia: A Risk Factor for Periprosthetic Joint Infection in Male Patients.
    Yazdi H; Restrepo C; Foltz C; Hammad M; Chung PH; Gomella LG; Parvizi J
    J Bone Joint Surg Am; 2020 Apr; 102(7):543-549. PubMed ID: 32079872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
    Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model.
    Udeh EI; Ofoha CG; Adewole DA; Nnabugwu II
    BMC Cancer; 2016 Jul; 16():405. PubMed ID: 27388750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.